
MedTech & Devices
FDA extends Casgevy approval to children aged two and over, raising payer coverage questions
The label extension widens the eligible population considerably while leaving outcome-based contracting unresolved.
News · Category
Medical technology and device makers.

MedTech & Devices
The label extension widens the eligible population considerably while leaving outcome-based contracting unresolved.

MedTech & Devices

MedTech & Devices

MedTech & Devices
Showing 1–4 of 4 stories